or Try an Advanced Search...

    Treatment Of Hepatorenal Syndrome Stocks List

    Symbol Grade Name % Change
    BIVI D BioVie Inc. 1.09
    CPIX F Cumberland Pharmaceuticals Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Hepatorenal Syndrome Analgesics Clinical Development Clinical Medicine Constipation Digestive Diseases Drug Design Drugs FDA Fever Gastroenterology Hepatology Hepatotoxins Infusion Pump Liver Medication Medicine Orphan Drug Pain Paracetamol

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Hepatorenal Syndrome stocks.

    Symbol Grade Name Weight
    DFAC B Dimensional U.S. Core Equity 2 ETF 0.0
    VTI B Vanguard Total Stock Market ETF 0.0
    DFAT C Dimensional U.S. Targeted Value ETF 0.0
    DFAS B Dimensional U.S. Small Cap ETF 0.0
    VXF A Vanguard Extended Market ETF 0.0
    View all Treatment Of Hepatorenal Syndrome ETFs...
    Compare ETFs
    Compare DFAC to VXF Compare DFAT to DFAS Compare VTI to VXF

        Treatment Of Hepatorenal Syndrome Stocks Recent News

        Date Stock Title
        Oct 31 CPIX CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS
        Oct 31 BIVI (BIVI) - Analyzing BioVie's Short Interest
        Oct 29 BIVI BioVie Inc. Announces Closing of Registered Direct Offering
        Oct 28 BIVI UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
        Oct 28 BIVI BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Hepatorenal Syndrome Analgesics Clinical Development Clinical Medicine Constipation Digestive Diseases Drug Design Drugs FDA Fever Gastroenterology Hepatology Hepatotoxins Infusion Pump Liver Medication Medicine Orphan Drug Pain Paracetamol
        Treatment Of Hepatorenal Syndrome

        Treatment of hepatorenal syndrome (HRS) is aimed at improving kidney function and preventing further damage to the kidneys. Treatment options may include medications to reduce the amount of fluid in the body, medications to reduce the amount of toxins in the blood, and dialysis. In some cases, a liver transplant may be necessary.

        Browse All Tags